|
PSMD14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.96120000017785E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.951800E-04 |
| Normal-vs-Stage2 |
4.243100E-03 |
| Normal-vs-Stage3 |
1.462610E-03 |
| Normal-vs-Stage4 |
9.662400E-03 |
| Stage1-vs-Stage2 |
1.415210E-01 |
| Stage1-vs-Stage3 |
3.810400E-02 |
| Stage1-vs-Stage4 |
1.721500E-02 |
| Stage2-vs-Stage3 |
7.660600E-01 |
| Stage2-vs-Stage4 |
3.036400E-01 |
| Stage3-vs-Stage4 |
4.655800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.50384999999531E-05 |
| Normal-vs-AfricanAmerican |
6.384100E-04 |
| Normal-vs-Asian |
1.281760E-01 |
| Caucasian-vs-AfricanAmerican |
4.922600E-01 |
| Caucasian-vs-Asian |
1.808810E-01 |
| AfricanAmerican-vs-Asian |
3.306000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.318900E-03 |
| Normal-vs-Female |
1.34390054640221E-10 |
| Male-vs-Female |
1.63329999969264E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.180000E-03 |
| Normal-vs-Extreme_Weight |
1.696390E-02 |
| Normal-vs-Obese |
1.616140E-03 |
| Normal-vs-Extreme_Obese |
2.180400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.631640E-01 |
| Normal_Weight-vs-Obese |
9.394400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.942800E-01 |
| Extreme_Weight-vs-Obese |
1.446850E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.417400E-01 |
| Obese-vs-Extreme_Obese |
8.286800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.171800E-04 |
| Normal-vs-Age(41-60Yrs) |
1.02609999996783E-06 |
| Normal-vs-Age(61-80Yrs) |
1.521170E-03 |
| Normal-vs-Age(81-100Yrs) |
3.221000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.456300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.203100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.115800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.667180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.684600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.796800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.420780E-03 |
| Normal-VS-Type2 PRCC |
5.390200E-04 |
| Normal-VS-KIRP CIMP |
4.37620000004468E-06 |
| Normal-VS-Unclassified PRCC |
2.577900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.139830E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.55980003649859E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
4.534500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.555000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
6.973200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.44410000000062E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.178400E-03 |
| Normal-vs-N1 |
2.609900E-04 |
| Normal-vs-N2 |
2.150200E-01 |
| N0-vs-N1 |
5.199600E-02 |
| N0-vs-N2 |
3.167400E-01 |
| N1-vs-N2 |
9.560600E-01 |
|
|
